(Q43590711)

English

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

scientific article published on 6 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

0 references

inflammatory bowel diseases

1 reference

based on heuristic

inferred from title

author name string

Kaija-Leena Kolho

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Taina Sipponen

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

434-441

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Infliximab efficacy in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Outcome following infliximab therapy in children with ulcerative colitis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Assessing response and loss of response to biological therapies in IBD.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

High-sensitivity C-reactive protein in paediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.886719

21 January 2018

Identifiers

10.3109/00365521.2014.886719

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43590711&oldid=2101733041"